Tarver took the position in late July after the announcement that CDRH’s director of the past 15 years, Jeff Shuren, M.D., ...

Industry leaders explored the risks and benefits of adopting a China Plus One strategy at Advamed’s The MedTech Conference in ...

Regulators and medical device companies discussed recent attacks and how to prevent them at Advamed’s The Medtech Conference ...

As medtech companies, experts and regulators gather in Toronto, FDA leadership changes and the upcoming U.S. presidential ...

CMS intends to speed payment decisions for as many as five "breakthrough" medical devices a year, potentially getting them to ...

Canada’s device agency plans to issue guidance on machine learning, and the FDA plans to release a draft guidance next year on lifecycle management and premarket submissions for AI devices.

*Based on data released by the Federal Election Commission on October 08, 2024 except for independent expenditure and communication cost, contributions to federal candidates, and contributions from ...

As a member of the Executive Committee of the AdvaMed Board of Directors, he contributes to strategic initiatives that advance the medical technology sector. He also serves on the AdvaMedDx Board ...